Journey Medical CORP (DERM) — 10-Q Filings

10-Q Filings (6)

• Journey Medical Narrows Losses, Boosts Revenue Amid ATM Offering — Nov 12, 2025 Risk: high
  Journey Medical Corp (DERM) reported a net loss of $10.184 million for the nine months ended September 30, 2025, an improvement from the $16.193 million net los
• Journey Medical Narrows Losses, Emrosi Approval Boosts Outlook — Aug 12, 2025 Risk: high
  Journey Medical Corp (DERM) reported a net loss of $7.87 million for the six-month period ended June 30, 2025, an improvement from the $13.80 million net loss i
• Journey Medical Corp. Files Q1 2025 10-Q — May 15, 2025 Risk: low
  Journey Medical Corp. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including com
• Journey Medical Corp. Q3 2024 10-Q Filed — Nov 12, 2024 Risk: low
  Journey Medical Corp. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter of 2024, detailing c
• Journey Medical Corp. Files Q2 2024 10-Q — Aug 13, 2024 Risk: low
  Journey Medical Corp. filed a 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter.
• Journey Medical Corp Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk: medium
  Journey Medical Corp (DERM) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Journey Medical Corp filed a 10-Q for the period ending March 31, 2024

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX